Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
876,7 INR | -0,76% | +3,94% | +35,03% |
09/04 | Strides Pharma Science krijgt goedkeuring van de Amerikaanse FDA voor fluoxetine-tabletten | MT |
30/01 | Transcript : Strides Pharma Science Limited, Q3 2024 Earnings Call, Jan 30, 2024 |
Vakgebied
Aantal werknemers: 2 850
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 30 703 | 100,0 % | 36 884 | 100,0 % | +20,13% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
North America
52,2
%
| 12 059 | 39,3 % | 19 261 | 52,2 % | +59,73% |
Europe
22,7
%
| 6 769 | 22,0 % | 8 370 | 22,7 % | +23,66% |
Africa
12,2
%
| 5 707 | 18,6 % | 4 506 | 12,2 % | -21,05% |
Australia
8,4
%
| 3 175 | 10,3 % | 3 116 | 8,4 % | -1,86% |
Global
2,2
%
| 482 | 1,6 % | 807 | 2,2 % | +67,49% |
Asia (excluding India)
1,2
%
| 1 971 | 6,4 % | 461 | 1,2 % | -76,63% |
India
0,6
%
| 473 | 1,5 % | 219 | 0,6 % | -53,82% |
Others
0,4
%
| 67 | 0,2 % | 144 | 0,4 % | +115,54% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Arun N. Kumar
CEO | Chief Executive Officer | 63 | 28-06-90 |
Badree Komandur
DFI | Director of Finance/CFO | - | 01-02-10 |
Compliance Officer | - | 03-02-17 | |
Corporate Officer/Principal | - | 01-10-22 | |
Amit Gupta
AUD | Comptroller/Controller/Auditor | - | - |
Rj Ramesh
TRE | Treasurer | - | - |
Sormistha Ghosh
LAW | General Counsel | - | - |
Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Arun N. Kumar
CEO | Chief Executive Officer | 63 | 28-06-90 |
Director/Board Member | 80 | 18-05-17 | |
Director/Board Member | 63 | 27-07-12 | |
Director/Board Member | 77 | 25-07-14 | |
Director/Board Member | 62 | 01/02 | |
Badree Komandur
DFI | Director of Finance/CFO | - | 01-02-10 |
Director/Board Member | 56 | 11-12-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 91 899 714 | 62 756 717 ( 68,29 %) | 0 | 68,29 % |
Bedrijfsgegevens
Strides Pharma Science Ltd.
Strides House Bannerghatta Road
560076, Bangalore
+91 80 6784 0000
http://www.strides.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Strides Pharma UK Ltd.
Strides Pharma UK Ltd. Medical DistributorsDistribution Services Strides Pharma UK Ltd. engages in the acquisition, development, marketing and distribution of a wide range of generic medicines and other over the counter products. It provides anti emetic, histamine, infective spasticity medicines, cardiovascular, dental, dermatology, diuretics, nasal, lubricants, and steroids medicines. The company was founded in 1993 and is headquartered in Watford, the United Kingdom. |
Medical Distributors
|
Strides Pharma Global Pte Ltd.
Strides Pharma Global Pte Ltd. Pharmaceuticals: MajorHealth Technology Strides Pharma Global Pte Ltd. manufactures and distributes pharmaceutical products. The company was founded in 2013 and is headquartered in Singapore. |
Pharmaceuticals: Major
|
Strides Pharma, Inc.
Strides Pharma, Inc. Pharmaceuticals: MajorHealth Technology Strides Pharma, Inc. manufactures and distributes pharmaceutical products. The firm operates through the following brand name: JointFlex, Pedia Care, and NiteThru. The company is headquartered in Lambertville, NJ. |
Pharmaceuticals: Major
|
Vivimed Life Sciences Pvt Ltd.
Vivimed Life Sciences Pvt Ltd. Pharmaceuticals: MajorHealth Technology Vivimed Life Sciences Pvt Ltd. provides pharmaceutical services. The joint venture company is based in Hyderabad, India and was founded in 2017. |
Pharmaceuticals: Major
|
Arco Lab Pvt Ltd.
Arco Lab Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Strides Pharma Science Ltd., Arco Lab Pvt Ltd. is a private company based in Bengaluru, India. |
Miscellaneous Commercial Services
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+35,03% | 966 mln. | |
+19,62% | 43,34 mld. | |
+20,44% | 21,96 mld. | |
+10,86% | 14,09 mld. | |
+13,07% | 13,64 mld. | |
+37,46% | 11,43 mld. | |
-8,59% | 6,86 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+8,46% | 5,22 mld. |
- Beurs
- Aandelen
- Koers STAR
- Onderneming Strides Pharma Science Limited